Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany.
J Refract Surg. 2013 Mar;29(3):187-93. doi: 10.3928/1081597X-20130212-01.
To analyze the refractive outcomes and safety of three-piece silicone toric sulcus-fixated add-on intraocular lenses (IOLs) (HumanOptics/Dr.Schmidt Intraocularlinsen, Erlangen, Germany) in complex clinical cases with high astigmatism such as in cases with previous penetrating keratoplasty.
Interventional case series of 21 eyes of 20 patients enrolled at two German centers. Functional results including power vector analysis, accuracy of IOL power calculation, rotational stability, and postoperative complications were evaluated from 2 months to 6 years postoperatively.
The preoperative subjective cylinder exceeded or was equal to -6.00 diopters (D) in 81% of eyes (range: -2.00 to -17.00 D). The median follow-up period was 7.6 months (range: 57 days to 6 years). The efficacy analysis focused on the 2 to 6 months follow-up visit. Postoperatively, there was a median reduction of astigmatism by 70.59% (subjective cylinder range: 0.00 to -5.00 D), improvement of uncorrected distance visual acuity, and unchanged median corrected distance visual acuity. The attempted spherical equivalent was achieved within ± 0.50 D in 45% and within ± 1.00 D in 65% of cases. Five eyes received secondary surgical alignment of axis. Other complications related to the surgical procedure were mainly transient shortly after implantation, such as intraocular pressure elevation (2 of 21 eyes) or corneal edema (2 of 21 eyes). Persisting changes were seen only in rare cases and included pigment dispersion (1 of 21 eyes) or corneal edema requiring a second keratoplasty within 9 months after surgery (2 of 21 eyes).
Toric add-on IOLs may be useful in reducing high astigmatism and anisometropia and increasing spectacle independence even in complex clinical conditions with high refractive errors.
分析 20 名患者的 21 只眼在德国两家中心接受三襻硅胶散光型巩膜固定型眼内透镜(HumanOptics/Dr.Schmidt Intraocularlinsen,德国埃尔兰根)治疗的屈光结果和安全性。这些复杂的临床病例具有较高的散光,如既往穿透性角膜移植术后。
回顾性系列病例研究。纳入 20 名患者的 21 只眼。术后 2 个月至 6 年,评估包括视力向量分析在内的功能结果、眼内透镜屈光力计算的准确性、旋转稳定性和术后并发症。
术前主观散光柱镜度超过或等于-6.00 屈光度(D)的眼占 81%(范围:-2.00 至-17.00 D)。中位随访时间为 7.6 个月(范围:57 天至 6 年)。疗效分析集中在术后 2 至 6 个月的随访期。术后平均散光降低 70.59%(主观柱镜度范围:0.00 至-5.00 D),未矫正远视力提高,中位矫正远视力不变。尝试达到的等效球镜屈光度在±0.50 D 以内的占 45%,在±1.00 D 以内的占 65%。5 只眼接受了轴位的二次手术矫正。与手术相关的其他并发症主要是短暂的,如植入后眼压升高(21 眼中 2 眼)或角膜水肿(21 眼中 2 眼)。仅在少数情况下观察到持续变化,包括色素播散(21 眼中 1 眼)或术后 9 个月内需要再次行角膜移植的角膜水肿(21 眼中 2 眼)。
即使在高屈光不正的复杂临床情况下,散光型巩膜固定型眼内透镜也可用于降低高度散光和屈光不正性弱视,并提高戴镜的独立性。